Last week the U.S. and China signed Phase One of most people anticipate will eventually prove to be a long-term trade deal. Investors are now anxiously awaiting Phase Two discussions, and while an actual, next-stage agreement could take some time, you can bet investors are going to be watching with as much interest and uncertainty […]
Read MoreAs Pier 1 struggles, these 4 retailers could see a bump in sales.
Read MoreCuban said this factor will determine what happens next for the “frothy” stock market.
Read MoreInvestors shouldn’t stay on the sidelines in 2020, according to the Bridgewater Associates founder. This is where to be instead.
Read MoreTrade Setup Buy Target $1.45 Sell Target $1.58 ReneSola Ltd, through its subsidiaries, develops, builds, operates, and sells solar power projects. It operates through three segments: Solar Power Project Development, EPC Services, and Electricity Generation Revenue. The company also develops community solar gardens; and sells projects rights. In addition, its engineering, and procurement and construction […]
Read MorePlus, the UN has called for an investigation into whether the Saudi Crown Prince was involved in hacking Amazon’s Bezos’ iPhone, Tesla got another upgrade, and Boeing said it doesn’t expect regulatory approval for its 737 Max until mid-year.
Read MoreOne of the interesting headlines I noticed yesterday in market news was that Amazon.com (AMZN) had filed paperwork for international trademarks on “Amazon Pharmacy.” The Pharmacy industry is one that I like to think of as a good, conservative industry when the market could be reaching a period of increasing uncertainty and concern about a […]
Read MoreBuy Target – $4.00 or better Sell Target – TradersPro Sell Signal Soleno Therapeutics, Inc. focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. The company’s lead candidate, Diazoxide Choline Controlled Release (DCCR), a once-daily oral tablet for the treatment of Prader-Willi Syndrome (PWS), is being evaluated in a […]
Read MoreTrade Setup Buy Target $3.25 Sell Target $3.87 Nano Dimension Ltd., through its subsidiaries, operates as an additive electronics provider. The company offers DragonFly Pro precision system for additive manufacturing of printed electronics. It also develops conductive and dielectric ink, as well as provides Dragonfly and Switch software to manage design file and printing process.
Read MoreBuy Target – $9.50 or better Sell Target – TradersPro Sell Signal Perma-Fix Environmental Services, Inc., through its subsidiaries, operates as an environmental and technology know-how company in the United States. It operates in three segments: Treatment, Services, and Medical. The Treatment segment offers nuclear, low-level radioactive, mixed waste, hazardous and non-hazardous waste treatment, and […]
Read MorePlus, Trump’s impeachment trial gets underway in the Senate today, the World Economic Forum in Davos kicked off, and earnings season marches on with Halliburton reporting.
Read MoreLast week, the U.S. and China finally signed the first phase of what everybody hopes ultimately becomes a long-term trade agreement. That, along with expectations that central banks all over the globe will continue to follow the Federal Reserve’s accommodative lead have a lot of investors looking hopefully into the rest of the year, looking […]
Read MoreBuy Target – $46.50 or better Sell Target – TradersPro Sell Signal Forty Seven, Inc., a clinical-stage immuno-oncology company, focuses on developing therapies to activate macrophages for the treatment of cancer. It is developing 5F9, a humanized IgG4 subclass monoclonal antibody against CD47 that is in Phase 1b/2 clinical trials used for the treatment of […]
Read MoreA little over a month ago, my constant search for value led me to put a lot of attention on the Energy sector. There are a lot of different aspects of the sector, including the Oil, Gas and Consumable Fuels industry that present a number of different, interesting opportunities to target oil & energy exploration, […]
Read MoreTrade Setup Buy Target $3.52 Sell Target $3.80 Pieris Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops anticalin-based drugs in the United States. The company develops anticalin proteins that are low molecular-weight therapeutic proteins derived from lipocalins, which are naturally occurring low-molecular weight human proteins found in blood plasma and other bodily fluids. Its […]
Read More